Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056328 · ClinicalTrials.gov registry record · NA
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 324
- Enrollment target
NCT01056328: Completed NA study, sponsored by Abbott Medical Devices.
NCT01056328 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 324 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01056328, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.
Interventions
- DEVICE SJM Irrigated Cardiac Ablation System
- DEVICE FDA approved Open Irrigated RF Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT01056328 record still lists
NCT01056328 is an interventional study that assigns participants to a tested intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which SJM Irrigated Cardiac Ablation System is the first listed.
NCT01056328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01056328 about?
NCT01056328 is a clinical study titled "Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)". The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.
What is the current status of trial NCT01056328?
This trial is currently completed. It is a NA study. The enrollment target is 324 participants. The study started on 2010-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01056328?
The interventions under investigation include: SJM Irrigated Cardiac Ablation System (DEVICE), FDA approved Open Irrigated RF Ablation System (DEVICE).
Who is sponsoring clinical trial NCT01056328?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01056328's enrollment target sits among peer trials
324 312th of 2000 higher than 1,686 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia